🔥🐔 BizChicken 🐔🔥
Companies Similar to Adaptive Biotechnologies Corporation
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
AnaptysBio, Inc.
Imsidolimab, Rosnilimab, ANB032
Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.
Symbol: ANAB
Recent Price: $13.22
Industry: Biotechnology
CEO: Mr. Daniel R. Faga
Sector: Healthcare
Employees: 117
Address: 10770 Wateridge Circle, San Diego, CA 92121-5801
Phone: 858 362 6295
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
INmune Bio, Inc.
INKmune
INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.
Symbol: INMB
Recent Price: $4.65
Industry: Biotechnology
CEO: Dr. Raymond Joseph Tesi M.D.
Sector: Healthcare
Employees: 11
Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432
Phone: 858 964 3720
Last updated: 2024-12-31
OmniAb, Inc.
Omni Ab platform
Omni Ab, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's platform leverages transgenic animals to generate human-like antibodies for therapeutic applications.
Symbol: OABI
Recent Price: $3.56
Industry: Biotechnology
CEO: Mr. Matthew W. Foehr
Sector: Healthcare
Employees: 106
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 510 250 7800
Leadership
- Matt Foehr, Chief Executive Officer
- Kurt Gustafson, Chief Financial Officer
- Charles Berkman, JD, Chief Legal Officer and Secretary
- Yasmina Abdiche, PhD, Vice President, Exploratory Research
- Laurel Bernstein, PhD, Vice President, Intellectual Property
- Neil Castle, PhD, Vice President, Biology
- Bob Chen, PhD, Sr. Director, Discovery Systems
- Ellen Collarini, PhD, Sr. Director, Cell Biology
- Bill Harriman, PhD, Sr. Vice President, Antibody Discovery
- Christel Iffland, PhD, Sr. Vice President, Antibody Technologies
- Shelley Izquierdo, PhD, Sr. Director, Antibody Discovery
- Doug Krafte, PhD, Site Head – Durham, North Carolina Sr. Vice President, Ion Channels/Transporters
- Phil Leighton, PhD, Fellow
- Cia McCaffrey, Vice President, People and Talent
- Anil Nair, PhD, Vice President, In Silico Discovery
- Todd Pettingill, CFA, Vice President, Business Development and Strategy
- Chris Silvia, PhD, Vice President, Data Sciences and Corporate IT
- Eric Vajda, PhD, Vice President, Preclinical R&D
- Marie-Cecile van de Lavoir, DVM, PhD, Sr. Vice President, Technical Operations and Genetics
- Donna Ventura, CPA, Sr. Vice President, Corporate Controller
- Carolyn R. Bertozzi, PhD, Board Member
- Sarah Boyce, President and Chief Executive Officer
- Jennifer Cochran, PhD, Board Member
- Matthew W. Foehr, President and Chief Executive Officer
- John Higgins, Board Chair
- Steve Love, Chief Financial Officer
Last updated: 2024-12-31
Sensei Biotherapeutics, Inc.
Immuno Phage platform
Sensei Biotherapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of immunotherapies for cancer, leveraging platforms such as Immuno Phage and Tumor Microenvironment Activated Biologics.
Symbol: SNSE
Recent Price: $0.48
Industry: Biotechnology
CEO: Mr. John K. Celebi M.B.A.
Sector: Healthcare
Employees: 28
Address: 451 D Street, Rockville, MD 02210
Phone: 240 243 8000
Last updated: 2024-12-31
Aditxt, Inc.
Aditxt Score
Aditxt, Inc. is a biotech company focused on developing technologies to improve immune system health through immune mapping and reprogramming. Their products include Aditxt Score for immune profiling and Apoptotic DNA Immunotherapy for inducing immune tolerance, with applications in organ transplantation, autoimmune diseases, and allergies.
About | About | About | About | Locations | About | Contact | Contact | About | About | About
Symbol: ADTX
Recent Price: $0.20
Industry: Biotechnology
CEO: Mr. Amro A. Albanna
Sector: Healthcare
Employees: 47
Address: 737 North Fifth Street, Richmond, VA 23219
Phone: 909 488 0844
Last updated: 2024-12-31
Cue Biopharma, Inc.
CUE-101
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing biologic drugs to modulate the human immune system for treating cancers, chronic infectious diseases, and autoimmune disorders.
About | Leadership | About | Directors | About | Contact | About | About | About | Careers | Careers | Careers | Careers | Careers | About
Symbol: CUE
Recent Price: $1.02
Industry: Biotechnology
CEO: Mr. Daniel R. Passeri J.D., M.Sc.
Sector: Healthcare
Employees: 53
Address: 21 Erie Street, Cambridge, MA 02139
Phone: 617 949 2680
Leadership
- Dan Passeri, Chief Executive Officer
- Anish Suri, President and Chief Scientific Officer
- Lucinda Warren, Chief Business Officer
- Matteo Levisetti, Chief Medical Officer
- Kerri-Ann Millar, Chief Financial Officer
- Colin Sandercock, Senior Vice President and General Counsel
- Frank Morich, M.D., Ph.D., Chairman of the Board
- Dan Passeri, M.Sc., J.D., Chief Executive Officer
- Peter Kiener, D.Phil.,
- Fred Driscoll,
- Patrick Verheyen,
- Pamela D. Garzone, Ph.D.,
Last updated: 2024-12-31
IGM Biosciences, Inc.
IGM-2323
IGM Biosciences, Inc. is a biotechnology company focused on developing Immunoglobulin M (Ig M) antibodies for treating cancer, infectious diseases, and autoimmune and inflammatory diseases. Their lead product candidate, IGM-2323, is in Phase 2 clinical trials for B cell Non-Hodgkin's lymphoma.
Symbol: IGMS
Recent Price: $6.05
Industry: Biotechnology
CEO: Ms. Mary Beth Harler M.D.
Sector: Healthcare
Employees: 204
Address: 325 East Middlefield Road, Mountain View, CA 94043
Phone: 650 965 7873
Last updated: 2024-12-31
Immunome, Inc.
IMM-ONC-01, IMM-BCP-01
Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.
Symbol: IMNM
Recent Price: $10.28
Industry: Biotechnology
CEO: Dr. Clay B. Siegall Ph.D.
Sector: Healthcare
Employees: 78
Address: 665 Stockton Drive, Exton, PA 19341
Phone: 610 321 3700
Last updated: 2024-12-31
Immuneering Corporation
IMM-1-104 and IMM-6-415
Immuneering Corporation is a biopharmaceutical company focused on developing oncology and neuroscience product candidates, with key products like IMM-1-104 for cancer treatment and IMM-6-415 for solid tumors.
Symbol: IMRX
Recent Price: $2.25
Industry: Biotechnology
CEO: Dr. Benjamin J. Zeskind M.B.A., Ph.D.
Sector: Healthcare
Employees: 66
Address: 245 Main Street, Cambridge, MA 02142
Phone: 617 500 8080
Last updated: 2024-12-31
Immunic, Inc.
IMU-838
Immunic, Inc. develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, in Phase 2 clinical trials for multiple conditions, including relapsing-remitting multiple sclerosis.
About | Vision/Values | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: IMUX
Recent Price: $1.03
Industry: Biotechnology
CEO: Dr. Daniel Vitt Ph.D.
Sector: Healthcare
Employees: 85
Address: 1200 Avenue of the Americas, New York, NY 10036
Phone: 332 255 9818
Last updated: 2024-12-31
Immunovant, Inc.
batoclimab
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases, including batoclimab for myasthenia gravis and thyroid eye disease.
Symbol: IMVT
Recent Price: $23.88
Industry: Biotechnology
CEO: Dr. Peter Salzmann M.B.A., M.D.
Sector: Healthcare
Employees: 207
Address: 320 West 37th Street, New York, NY 10018
Phone: 917 580 3099
Leadership
- Pete Salzmann, M.D., MBA, Chief Executive Officer
- Renee Barnett, MBA, Chief Financial Officer
- Christine Blodgett, Senior Vice President of Human Resources
- Andy Deig, Senior Vice President Strategic Finance
- Michael Geffner M.D., MBA, Chief Medical Officer
- Julie Kirschling, Senior Vice President, Program and Alliance Management
- Mark Levine, Chief Legal Officer and Corporate Secretary
- Bill Macias, M.D., Ph.D., Chief Medical Officer
- Becky Merlina, Senior Vice President, Global Head of Quality
- Jody Roth, MS, RAC, PMP, Senior Vice President, Regulatory Affairs
- Jay S. Stout, PhD, Chief Technology Officer
- Yan Zheng, Ph.D., Senior Vice President Biostatistics, Programming & Data Management
- Chandra Adams, Vice President, Associate General Counsel
- Maria Alba, M.D., Vice President of Clinical Development
- Farah Ali, Vice President, Clinical Development
- Jennifer Ashley, Vice President, Associate General Counsel
- Annetta Beauregard, Vice President, Regulatory Affairs Strategy
- Harry Berlanga, MSc., VP, CMC & Distribution Quality
- Ranjit Deshmukh, Ph.D., Vice President of CMC and Technical Operations
- Scott Forman, MBA, Vice President, Program Management
- Tom Forman, MBA, Vice President, CMC Project Management
- Ian Gourley, M.D., Vice President of Clinical Development
- Thomas Hardy, M.D., Ph.D., Vice President of Drug Safety and Pharmacovigilance
- Laci Hasenour, Vice President Marketing, Neurology
- Aileen Ilaria, MBA, Vice President, Clinical Operations – Global Site Management
- Claudia Jacobs, Ph.D., Vice President of CMC Project Management Operations and Clinical Supply
- Jonathan Janes, MB, Vice President Clinical Development
- Ant Kidwell, Vice President of IT and Facilities
- Chedvi Levin-Sister, Vice President of Finance
- Launi Masterson, Vice President of Clinical Operations
- Andy Minke, Vice President Program Management
- Linda McKerral, Vice President, CMC Analytical Sciences
- Pooja Mehta, Vice President Drug Substance Tech Transfer
- Regina Mirra, VP, Regulatory Operational Excellence
- Jennifer Moseley, Vice President of Clinical Operations
- Sheetal Patel M.D., MS MBA, Vice President of Clinical Development
- Cassandra Pauyo, Vice President, Data Management
- Rod Saponjic Ph.D., MBA, Vice President of Clinical Operations
- Lauren Schrier, MBA, Vice President of Marketing
- Frank Torti, M.D., Chairperson of Board of Directors
- Andrew Fromkin, Member of Board of Directors
- Douglas Hughes, Member of Board of Directors
- George Migausky, Member of Board of Directors
- Atul Pande, M.D., Member of Board of Directors
- Eric Venker, M.D., Pharm.D., Member of Board of Directors
Last updated: 2024-12-31
Indaptus Therapeutics, Inc.
Decoy20
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.
Symbol: INDP
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. Jeffrey A. Meckler
Sector: Healthcare
Employees: 7
Address: 3 Columbus Circle, New York, NY 10019
Phone: 347 480 9760
Last updated: 2024-12-31
NexImmune, Inc.
Artificial Immune Modulation
Nex Immune, Inc., a clinical-stage biotechnology company, develops therapies for cancer and immune-mediated diseases using its Artificial Immune Modulation platform. The company is advancing cell therapy candidates including NEXI-001, NEXI-002, and NEXI-003.
About | Leadership | About | About | About | About | Leadership | About | About | Contact | Contact | Contact | Careers | Careers | About | About | About | About
Symbol: NEXI
Recent Price: $0.15
Industry: Biotechnology
CEO: Mr. John Trainer M.B.A.
Sector: Healthcare
Employees: 6
Address: 9119 Gaither Road, Gaithersburg, MD 20877
Phone: 301 825 9810
Leadership
- Kristi Jones, Chief Executive Officer
- Mathias Oelke, Ph.D., Chief Scientific Officer
- Daniel Bednarik Ph.D., Senior Vice President, Molecular Engineering & Protein Design
- Jack Ragheb, Senior Vice President, Translational Science
- Tonya Catterton, Vice President, Quality & Compliance
- Tim Stover, Vice President, Corporate Controller
- Karen Haslbeck, Head, Human Resources
- Matt Schiller, Head, Business Development
Last updated: 2024-12-31
SAB Biotherapeutics, Inc.
SAB-185, SAB-176
SAB Biotherapeutics is a clinical-stage biopharmaceutical company focusing on developing immunotherapies based on human antibodies, using advanced genetic engineering to produce fully-human polyclonal antibodies targeting diseases such as COVID-19, influenza, autoimmune disorders, and cancer.
Symbol: SABS
Recent Price: $4.15
Industry: Biotechnology
CEO: Mr. Samuel J. Reich
Sector: Healthcare
Employees: 57
Address: 2100 East 54th Street North, Sioux Falls, SD 57104
Phone: 605 679 6980
Last updated: 2024-12-31
Vir Biotechnology, Inc.
Sotrovimab (VIR-7832), VIR-2218, VIR-3434, VIR-2482, VIR-1111
Vir Biotechnology, Inc. is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV.
Vision/Values | About | Leadership | About | Contact | Contact | Careers | Jobs | About | About
Symbol: VIR
Recent Price: $7.33
Industry: Biotechnology
CEO: Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Sector: Healthcare
Employees: 587
Address: 499 Illinois Street, San Francisco, CA 94158
Phone: 415 906 4324
Leadership
- Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer and Director
- Jeff Calcagno, M.D., Executive Vice President and Chief Business Officer
- Vanina de Verneuil, J.D., Executive Vice President, General Counsel and Corporate Secretary
- Mika Kakefuda Derynck, M.D., Executive Vice President, Therapeutic Area Head Oncology
- Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer
- Jenny Gumm, Ed.D., MBA, Executive Vice President, Chief Human Resources Officer
- Aine Hanly, Ph.D., Executive Vice President and Chief Technology Officer
- Jason O’Byrne, MBA, Executive Vice President and Chief Financial Officer
- Jennifer Eileen Towne, Ph.D., Executive Vice President and Chief Scientific Officer
- Arran Attridge, Senior Vice President Corporate Communications
- Antonio Lanzavecchia, M.D., Senior Vice President and Senior Research Fellow
- Amalio Telenti, M.D, Ph.D., Executive Vice President and Senior Research Fellow
Last updated: 2024-12-31
XBiotech Inc.
True Human monoclonal antibodies
XBiotech Inc. discovers, develops, and commercializes True Human monoclonal antibodies targeting inflammatory and infectious diseases, with additional development in interleukin-1 alpha therapies for various medical conditions and COVID-19 therapy.
Symbol: XBIT
Recent Price: $4.09
Industry: Biotechnology
CEO: Mr. John Simard
Sector: Healthcare
Employees: 94
Address: 5217 Winnebago Lane, Austin, TX 78744
Phone: 512 386 2900
Last updated: 2024-12-31
Adaptive Biotechnologies Corporation
immunoSEQ
Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.
Leadership | Contact | About | About | About | About | Careers | Careers | About | About | About | About | About
Symbol: ADPT
Recent Price: $6.11
Industry: Biotechnology
CEO: Mr. Chad M. Robins M.B.A.
Sector: Healthcare
Employees: 709
Address: 1165 Eastlake Avenue East, Seattle, WA 98109
Phone: 206 659 0067
Last updated: 2024-12-31
Aptevo Therapeutics Inc.
APVO436
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company specializing in the development of immunotherapeutic candidates to treat various forms of cancer, with a primary focus on APVO436, a bispecific T-cell engaging antibody for leukemia and myelodysplastic syndrome.
About | Leadership | Directors | About | Contact | About | Contact | Contact | Contact | About | Leadership | Directors | About | About | About | About | About | About | About | About | About | About | About
Symbol: APVO
Recent Price: $4.78
Industry: Biotechnology
CEO: Mr. Marvin L. White
Sector: Healthcare
Employees: 40
Address: 2401 4th Avenue, Seattle, WA 98121
Phone: 206 838 0500
Leadership
- Marvin L. White, President and Chief Executive Officer
- Jeff Lamothe, EVP and Chief Operating Officer
- Daphne Taylor, SVP and Chief Financial Officer
- Dirk Huebner, M.D., Chief Medical Officer
- SoYoung Kwon, SVP, General Counsel, Business Development and Corporate Affairs
Last updated: 2024-12-31
Immix Biopharma, Inc.
IMX-110, IMX-111, IMX-120
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.
Symbol: IMMX
Recent Price: $2.36
Industry: Biotechnology
CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Sector: Healthcare
Employees: 14
Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064
Phone: 310 651 8041
Last updated: 2024-12-31